个人中心 - 老虎社区

VinkaloZendo

IP属地：未知

帖子 · 12帖子 · 12
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- VinkaloZendoVinkaloZendo
  ·2021-11-18
  Ok
  非常抱歉，此主贴已删除
  728 1
  2
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-11-18
  Ok
  非常抱歉，此主贴已删除
  748 1
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-11-05
  Buy!
  非常抱歉，此主贴已删除
  811 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-19
  $TENCENT(00700)$ great!
  361 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-19
  Great read!
  非常抱歉，此主贴已删除
  1,097 评论
  4
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-16
  Agreed
  非常抱歉，此主贴已删除
  831 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-15
  More infor needed before making decision
  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
  Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange trad
  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
  772 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-15
  Good infor
  Novavax (NVAX) Gains As Market Dips: What You Should Know
  In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previ
  Novavax (NVAX) Gains As Market Dips: What You Should Know
  516 评论
  点赞
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-08
  Oh
  非常抱歉，此主贴已删除
  660 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-02
  Agreed
  非常抱歉，此主贴已删除
  616 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3584268106923844","uuid":"3584268106923844","gmtCreate":1621174881176,"gmtModify":1630478040905,"name":"VinkaloZendo","pinyin":"vinkalozendo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":29,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":878715653,"gmtCreate":1637232628288,"gmtModify":1637232628391,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878715653","repostId":"1143297999","repostType":4,"isVote":1,"tweetType":1,"viewCount":728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878715343,"gmtCreate":1637232593992,"gmtModify":1637232594048,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878715343","repostId":"2184486862","repostType":2,"isVote":1,"tweetType":1,"viewCount":748,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842032169,"gmtCreate":1636120029306,"gmtModify":1636120593133,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Buy!&nbsp;","listText":"Buy!&nbsp;","text":"Buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842032169","repostId":"2181743347","repostType":2,"isVote":1,"tweetType":1,"viewCount":811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887289804,"gmtCreate":1632044792708,"gmtModify":1632803149316,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00700\">$TENCENT(00700)$</a>&nbsp;great!&nbsp;","listText":"<a href=\"https://laohu8.com/S/00700\">$TENCENT(00700)$</a>&nbsp;great!&nbsp;","text":"$TENCENT(00700)$ great!","images":[{"img":"https://static.tigerbbs.com/75934610bd78ad682b4bfea4d47b2efd","width":"1080","height":"2399"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887289804","isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":887289932,"gmtCreate":1632044741226,"gmtModify":1632803149678,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Great read!&nbsp;","listText":"Great read!&nbsp;","text":"Great read!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887289932","repostId":"1198486138","repostType":4,"isVote":1,"tweetType":1,"viewCount":1097,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885522152,"gmtCreate":1631804508176,"gmtModify":1631890660013,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Agreed&nbsp;","listText":"Agreed&nbsp;","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885522152","repostId":"2167351025","repostType":2,"isVote":1,"tweetType":1,"viewCount":831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882897562,"gmtCreate":1631672029956,"gmtModify":1631890660015,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"More infor needed before making decision&nbsp;","listText":"More infor needed before making decision&nbsp;","text":"More infor needed before making decision","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882897562","repostId":"2167555562","repostType":2,"repost":{"id":"2167555562","kind":"news","pubTimestamp":1631614810,"share":"https://www.laohu8.com/m/news/2167555562?lang=&edition=full","pubTime":"2021-09-14 18:20","market":"us","language":"en","title":"Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2167555562","media":"Zacks","summary":"Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange trad","content":"<html><body><p>Launched on 05/05/2010, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.</p>\n<p><b>What Are Smart Beta ETFs?</b></p>\n<p>The ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.</p>\n<p>Investors who believe in market efficiency should consider market cap indexes, as they replicate market returns in a low-cost, convenient, and transparent way.</p>\n<p>On the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.</p>\n<p>This kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.</p>\n<p>Even though this space provides many choices to investors--think <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the simplest methodologies like equal-weighting and more complicated ones like fundamental and volatility/momentum based weighting--not all have been able to deliver first-rate results.</p>\n<p><b>Fund Sponsor &amp; Index</b></p>\n<p>The fund is managed by Blackrock, and has been able to amass over $467.26 million, which makes it one of the average sized ETFs in the Style Box - All Cap Blend. Before fees and expenses, this particular fund seeks to match the performance of the MSCI USA Equal Weighted Index.</p>\n<p>The MSCI USA Equal Weighted Index represents the MSCI USA Index, measures the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in the United States.</p>\n<p><b>Cost &amp; Other Expenses</b></p>\n<p>Cost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive cousins if all other fundamentals are the same.</p>\n<p>With one of the least expensive products in the space, this ETF has annual operating expenses of 0.09%.</p>\n<p>It's 12-month trailing dividend yield comes in at 1.08%.</p>\n<p><b>Sector Exposure and Top Holdings</b></p>\n<p>Even though ETFs offer diversified exposure that minimizes single stock risk, investors should also look at the actual holdings inside the fund. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.</p>\n<p>Representing 20% of the portfolio, the fund has heaviest allocation to the Information Technology sector; Healthcare and Industrials round out the top three.</p>\n<p>Looking at individual holdings, Novavax Inc (NVAX) accounts for about 0.24% of total assets, followed by <a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a> Inc (ENPH) and Moderna Inc (MRNA).</p>\n<p>The top 10 holdings account for about 2.27% of total assets under management.</p>\n<p><b>Performance and Risk</b></p>\n<p>So far this year, EUSA return is roughly 22.50%, and was up about 43.31% in the last one year (as of 09/14/2021). During this past 52-week period, the fund has traded between $59.14 and $88.24.</p>\n<p>The fund has a beta of 1.13 and standard deviation of 23.87% for the trailing three-year period, which makes EUSA a medium risk choice in this particular space. With about 632 holdings, it effectively diversifies company-specific risk.</p>\n<p><b>Alternatives</b></p>\n<p>IShares MSCI USA Equal Weighted ETF is a reasonable option for investors seeking to outperform the Style Box - All Cap Blend segment of the market. However, there are other ETFs in the space which investors could consider.</p>\n<p>IShares Core S&amp;P Total U.S. Stock Market ETF (ITOT) tracks S&amp;P Total Market Index and the Vanguard Total Stock Market ETF (VTI) tracks CRSP US Total Market Index. IShares Core S&amp;P Total U.S. Stock Market ETF has $42.71 billion in assets, Vanguard Total Stock Market ETF has $264.76 billion. ITOT has an expense ratio of 0.03% and VTI charges 0.03%.</p>\n<p>Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - All Cap Blend.</p>\n<p><b>Bottom Line</b></p>\n<p>To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/ISQMF\">iShares MSCI</a> USA Equal Weighted ETF (EUSA): ETF Research Reports\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (MRNA) : Free Stock Analysis Report\n<br/> \n<br/>\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n<br/> \n<br/>\nEnphase Energy, Inc. (ENPH) : Free Stock Analysis Report\n<br/> \n<br/>\nVanguard Total Stock Market ETF (VTI): ETF Research Reports\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/EEME\">iShares</a> Core S&amp;P Total U.S. Stock Market ETF (ITOT): ETF Research Reports\n<br/> \n<br/>\nTo read this article on Zacks.com click here.</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-14 18:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.\nWhat Are ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/clODVF3EcX410F.EsuMH4Q--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a","relate_stocks":{"EUSA":"iShares MSCI USA Index Fund","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2167555562","content_text":"Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.\nWhat Are Smart Beta ETFs?\nThe ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.\nInvestors who believe in market efficiency should consider market cap indexes, as they replicate market returns in a low-cost, convenient, and transparent way.\nOn the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.\nThis kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.\nEven though this space provides many choices to investors--think one of the simplest methodologies like equal-weighting and more complicated ones like fundamental and volatility/momentum based weighting--not all have been able to deliver first-rate results.\nFund Sponsor & Index\nThe fund is managed by Blackrock, and has been able to amass over $467.26 million, which makes it one of the average sized ETFs in the Style Box - All Cap Blend. Before fees and expenses, this particular fund seeks to match the performance of the MSCI USA Equal Weighted Index.\nThe MSCI USA Equal Weighted Index represents the MSCI USA Index, measures the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in the United States.\nCost & Other Expenses\nCost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive cousins if all other fundamentals are the same.\nWith one of the least expensive products in the space, this ETF has annual operating expenses of 0.09%.\nIt's 12-month trailing dividend yield comes in at 1.08%.\nSector Exposure and Top Holdings\nEven though ETFs offer diversified exposure that minimizes single stock risk, investors should also look at the actual holdings inside the fund. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.\nRepresenting 20% of the portfolio, the fund has heaviest allocation to the Information Technology sector; Healthcare and Industrials round out the top three.\nLooking at individual holdings, Novavax Inc (NVAX) accounts for about 0.24% of total assets, followed by Enphase Energy Inc (ENPH) and Moderna Inc (MRNA).\nThe top 10 holdings account for about 2.27% of total assets under management.\nPerformance and Risk\nSo far this year, EUSA return is roughly 22.50%, and was up about 43.31% in the last one year (as of 09/14/2021). During this past 52-week period, the fund has traded between $59.14 and $88.24.\nThe fund has a beta of 1.13 and standard deviation of 23.87% for the trailing three-year period, which makes EUSA a medium risk choice in this particular space. With about 632 holdings, it effectively diversifies company-specific risk.\nAlternatives\nIShares MSCI USA Equal Weighted ETF is a reasonable option for investors seeking to outperform the Style Box - All Cap Blend segment of the market. However, there are other ETFs in the space which investors could consider.\nIShares Core S&P Total U.S. Stock Market ETF (ITOT) tracks S&P Total Market Index and the Vanguard Total Stock Market ETF (VTI) tracks CRSP US Total Market Index. IShares Core S&P Total U.S. Stock Market ETF has $42.71 billion in assets, Vanguard Total Stock Market ETF has $264.76 billion. ITOT has an expense ratio of 0.03% and VTI charges 0.03%.\nInvestors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - All Cap Blend.\nBottom Line\nTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\niShares MSCI USA Equal Weighted ETF (EUSA): ETF Research Reports\n \n\nModerna, Inc. (MRNA) : Free Stock Analysis Report\n \n\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n \n\nEnphase Energy, Inc. (ENPH) : Free Stock Analysis Report\n \n\nVanguard Total Stock Market ETF (VTI): ETF Research Reports\n \n\niShares Core S&P Total U.S. Stock Market ETF (ITOT): ETF Research Reports\n \n\nTo read this article on Zacks.com click here.","news_type":1,"symbols_score_info":{"EUSA":1,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":772,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882897995,"gmtCreate":1631671991517,"gmtModify":1631890660017,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Good infor","listText":"Good infor","text":"Good infor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882897995","repostId":"2167563598","repostType":2,"repost":{"id":"2167563598","kind":"news","pubTimestamp":1631655909,"share":"https://www.laohu8.com/m/news/2167563598?lang=&edition=full","pubTime":"2021-09-15 05:45","market":"us","language":"en","title":"Novavax (NVAX) Gains As Market Dips: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2167563598","media":"Zacks","summary":"In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previ","content":"<html><body><p>In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&amp;P 500's 0.58% loss on the day.</p>\n<p>Prior to today's trading, shares of the vaccine maker had gained 1.97% over the past month. This has outpaced the Medical sector's loss of 0.62% and the S&amp;P 500's gain of 0.16% in that time.</p>\n<p>Investors will be hoping for strength from NVAX as it approaches its next earnings release. In that report, analysts expect NVAX to post earnings of -$4.04 per share. This would mark a year-over-year decline of 25.86%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $306.8 million, up 95.39% from the year-ago period.</p>\n<p>Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$8.37 per share and revenue of $1.77 billion. These totals would mark changes of -15.13% and +273.17%, respectively, from last year.</p>\n<p>Investors should also note any recent changes to analyst estimates for NVAX. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.</p>\n<p>Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.</p>\n<p>The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.86% lower within the past month. NVAX is currently a Zacks Rank #3 (Hold).</p>\n<p>The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.</p>\n<p>The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.</p>\n<p>Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax (NVAX) Gains As Market Dips: What You Should Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax (NVAX) Gains As Market Dips: What You Should Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 05:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&P 500's 0.58% loss on the day.\nPrior to today's trading, shares ...</p>\n\n<a href=\"https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/r3XbmSiK8NsZqGuIQaOcPA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2167563598","content_text":"In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&P 500's 0.58% loss on the day.\nPrior to today's trading, shares of the vaccine maker had gained 1.97% over the past month. This has outpaced the Medical sector's loss of 0.62% and the S&P 500's gain of 0.16% in that time.\nInvestors will be hoping for strength from NVAX as it approaches its next earnings release. In that report, analysts expect NVAX to post earnings of -$4.04 per share. This would mark a year-over-year decline of 25.86%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $306.8 million, up 95.39% from the year-ago period.\nLooking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$8.37 per share and revenue of $1.77 billion. These totals would mark changes of -15.13% and +273.17%, respectively, from last year.\nInvestors should also note any recent changes to analyst estimates for NVAX. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.\nBased on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.\nThe Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.86% lower within the past month. NVAX is currently a Zacks Rank #3 (Hold).\nThe Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.\nThe Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.\nBe sure to follow all of these stock-moving metrics, and many more, on Zacks.com.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.","news_type":1,"symbols_score_info":{"NVAX":1}},"isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889933352,"gmtCreate":1631100972376,"gmtModify":1631890660021,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/889933352","repostId":"2165360472","repostType":4,"isVote":1,"tweetType":1,"viewCount":660,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812648880,"gmtCreate":1630586864540,"gmtModify":1631890660024,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Agreed","listText":"Agreed","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812648880","repostId":"1100563900","repostType":2,"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}